Literature DB >> 11524714

Minimizing potential resistance: a population dynamics view.

B R Levin1.   

Abstract

I examine the results of studies that used mathematical models of the epidemiology and population genetics of antibiotic treatment and resistance in open communities and in hospitals to explore the following issues: the relationship between antibiotic consumption and the frequency of antibiotic resistance in bacterial populations in communities and in hospitals; methods of controlling the growth, dissemination, and persistence of antibiotic resistance in these settings; the extent to which resistance can be controlled; and the speed with which the effects of control measures will be realized. In open communities, it will take years or even decades to see substantial reductions in the frequency of antibiotic resistance solely as a result of more prudent (reduced) use of antibiotics. However, if we can restrict the input of resistant bacteria into hospitals, through the application of infection control and other measures, it should be possible to reduce the frequency of resistance and even eliminate resistant bacteria from these institutions in short order.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524714     DOI: 10.1086/321843

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  46 in total

Review 1.  Antibiotics in agriculture: when is it time to close the barn door?

Authors:  Marc Lipsitch; Randall S Singer; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

2.  Old drugs for new bugs.

Authors:  Silvio Pitlik
Journal:  BMJ       Date:  2003-02-01

3.  Origins of community strains of methicillin-resistant Staphylococcus aureus.

Authors:  Edwin D Charlebois; Françoise Perdreau-Remington; Barry Kreiswirth; David R Bangsberg; Daniel Ciccarone; Binh A Diep; Valerie L Ng; Kimberly Chansky; Brian R Edlin; Brian Edlin; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2004-06-01       Impact factor: 9.079

4.  Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Authors:  David L Smith; Jonathan Dushoff; Eli N Perencevich; Anthony D Harris; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

5.  Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.

Authors:  Aránzazu Valverde; Teresa M Coque; M Paz Sánchez-Moreno; Azucena Rollán; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 6.  Mathematical modeling of the transmission and control of foodborne pathogens and antimicrobial resistance at preharvest.

Authors:  Cristina Lanzas; Zhao Lu; Yrjo T Gröhn
Journal:  Foodborne Pathog Dis       Date:  2010-11-02       Impact factor: 3.171

7.  Combining mathematical models and statistical methods to understand and predict the dynamics of antibiotic-sensitive mutants in a population of resistant bacteria during experimental evolution.

Authors:  Leen De Gelder; José M Ponciano; Zaid Abdo; Paul Joyce; Larry J Forney; Eva M Top
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

8.  The community-wide dilemma of hospital-acquired drug resistance.

Authors:  Leslie A Real
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

9.  Screening strategies in surveillance and control of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  J V Robotham; D R Jenkins; G F Medley
Journal:  Epidemiol Infect       Date:  2006-07-13       Impact factor: 2.451

10.  Prevalence and treatment outcome of cervicitis of unknown etiology.

Authors:  Stephanie N Taylor; Shelly Lensing; Jane Schwebke; Rebecca Lillis; Leandro A Mena; Anita L Nelson; Anne Rinaldi; Lisa Saylor; Linda McNeil; Jeannette Y Lee
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.